Receive the latest alerts via email

New stock valuation – Regeneron Pharmaceuticals Inc(REGN)

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) under-valued by 7%

Website https://www.regeneron.com/
Sector Healthcare
Industry Biotechnology
Fiscal Year End Dec 31, 2019
Market Cap $62,258,471,000
Beta 0.40139
Average Volume $852,186
Last Dividend 0%
Price on Aug 5, 2020 $600.82
Autochartist™ Valuation $644.81
Conclusion
7%
under-valued
Download Report
Total
0
Shares
Previous Post

New stock valuation – Broadridge Financial Solutions Inc(BR)

Next Post

New stock valuation – Broadridge Financial Solutions Inc(BR)

Related Posts